{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-003450","form_type":"8-K","ticker":"PAYS","cik":"0001496443","company_name":"Paysign, Inc.","filed_at":"2022-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.914612+00:00","generated_at":"2026-06-25T20:49:12.239968+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Paysign Q1 revenue $8.2M (+31% YoY), net loss $0.3M; reaffirms FY2022 guidance","bullets":["Revenue $8.2M vs $6.3M in Q1 2021; net loss $0.3M (($0.01) per share).","Plasma revenue up 37% to $7.4M; added 9 new centers, exiting with 375 total.","Pharma revenue down 9% to $0.8M; launched 4 new copay programs during quarter.","Adjusted EBITDA positive at $0.9M ($0.02/share) vs negative in Q1 2021.","FY2022 outlook unchanged: revenue $35.25M-$38.35M, adj. EBITDA at least $4.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-003450","json":"https://secwatch.observer/filing/0001683168-22-003450.json","markdown":"https://secwatch.observer/filing/0001683168-22-003450.md","text":"https://secwatch.observer/filing/0001683168-22-003450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1496443/000168316822003450/0001683168-22-003450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1496443/000168316822003450/paysign_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T20:49:12.239968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}